Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Excitatory Amino Acid Antagonists"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 2246
Tytuł:
Combining a noble gas with radiotherapy: glutamate receptor antagonist xenon may act as a radiosensitizer in glioblastoma.
Autorzy:
Büttner, Thomas (AUTHOR)
Maerevoet, Marielena K. E. (AUTHOR)
Giordano, Frank A. (AUTHOR)
Veldwijk, Marlon R. (AUTHOR)
Herskind, Carsten (AUTHOR)
Ruder, Arne Mathias (AUTHOR)
Pokaż więcej
Źródło:
Radiation Oncology. 1/30/2024, Vol. 19, p1-10. 10p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina.
Autorzy:
Papadogkonaki, Sofia (AUTHOR)
Spyridakos, Dimitris (AUTHOR)
Lapokonstantaki, Emmanouela (AUTHOR)
Chaniotakis, Nikos (AUTHOR)
Makriyannis, Alexandros (AUTHOR)
Malamas, Michael S. (AUTHOR)
Thermos, Kyriaki (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Nov2023, Vol. 24 Issue 21, p15689. 21p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Targeting Autophagy, Apoptosis, and SIRT1/Nrf2 Axis with Topiramate Underlies Its Neuroprotective Effect against Cadmium-Evoked Cognitive Deficits in Rats.
Autorzy:
Arab, Hany H. (AUTHOR)
Eid, Ahmed H. (AUTHOR)
Yahia, Rania (AUTHOR)
Alsufyani, Shuruq E. (AUTHOR)
Ashour, Ahmed M. (AUTHOR)
El-Sheikh, Azza A. K. (AUTHOR)
Darwish, Hany W. (AUTHOR)
Saad, Muhammed A. (AUTHOR)
Al-Shorbagy, Muhammad Y. (AUTHOR)
Masoud, Marwa A. (AUTHOR)
Pokaż więcej
Źródło:
Pharmaceuticals (14248247). Sep2023, Vol. 16 Issue 9, p1214. 24p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Oleic acid‐induced interleukin‐36γ: A possible link between facial skin redness and sebum.
Autorzy:
Kawamoto, Akane (AUTHOR)
Kuwano, Tetsuya (AUTHOR)
Watarai, Etsuko (AUTHOR)
Igarashi, Takanori (AUTHOR)
Katayama, Yasushi (AUTHOR)
Kushida, Ken (AUTHOR)
Nakamura, Shun (AUTHOR)
Murase, Takatoshi (AUTHOR)
Yoshida, Hiroyuki (AUTHOR)
Ishikawa, Junko (AUTHOR)
Pokaż więcej
Źródło:
Journal of Cosmetic Dermatology. Aug2023, Vol. 22 Issue 8, p2308-2317. 10p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Esmethadone-HCl (REL-1017): a promising rapid antidepressant.
Autorzy:
Fava M; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, 02114, USA.
Stahl SM; Department of Psychiatry, VAMC (SD), University of California, San Diego, La Jolla, CA, 92093, USA.; Neuroscience Education Institute, Carlsbad, CA, 92008, USA.
De Martin S; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, 35122, Padua, Italy.
Mattarei A; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, 35122, Padua, Italy.
Bettini E; In Vitro Pharmacology Department, Aptuit, an Evotec Company, 37135, Verona, Italy.
Comai S; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, 35122, Padua, Italy.; Department of Biomedical Sciences, University of Padua, 35122, Padua, Italy.; Department of Psychiatry, McGill University, Montreal, QC, H3A 1A1, Canada.
Alimonti A; Department of Health Sciences and Technology, ETH Zurich, 8092, Zurich, Switzerland.; Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland (IOSI), 6500, Bellinzona, Switzerland.; Università della Svizzera Italiana, 6900, Lugano, Switzerland.; Veneto Institute of Molecular Medicine, 35129, Padua, Italy.; Department of Medicine-DIMED, University of Padua, 35122, Padua, Italy.
Bifari F; Department of Medical Biotechnology and Translational Medicine, University of Milan, 20122, Milan, Italy.
Pani L; Relmada Therapeutics, Coral Gables, FL, 33134, USA.; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Miami, Miami, FL, 33146, USA.; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41121, Modena, Italy.
Folli F; Department of Health Sciences, University of Milan, 20122, Milan, Italy.
Guidetti C; Child and Adolescent Neuropsychiatry Unit, Department of Neuroscience, Bambino Gesù Pediatric Hospital, 00165, Rome, Italy.
Furlan A; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, 35122, Padua, Italy.
Sgrignani J; Institute for Research in Biomedicine (IRB), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.
Locatelli P; Institute for Research in Biomedicine (IRB), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.
Cavalli A; Institute for Research in Biomedicine (IRB), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.; Swiss Institute of Bioinformatics, 1015, Lausanne, Switzerland.
O'Gorman C; Relmada Therapeutics, Coral Gables, FL, 33134, USA.
Traversa S; Relmada Therapeutics, Coral Gables, FL, 33134, USA.
Inturrisi CE; Relmada Therapeutics, Coral Gables, FL, 33134, USA.
Pappagallo M; Relmada Therapeutics, Coral Gables, FL, 33134, USA.
Manfredi PL; Relmada Therapeutics, Coral Gables, FL, 33134, USA. .
Pokaż więcej
Źródło:
European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2023 Oct; Vol. 273 (7), pp. 1463-1476. Date of Electronic Publication: 2023 Mar 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Depressive Disorder, Major*/drug therapy
Alzheimer Disease*/drug therapy
Humans ; Excitatory Amino Acid Antagonists/pharmacology ; Memantine/pharmacology ; Memantine/therapeutic use ; Antidepressive Agents/pharmacology ; Antidepressive Agents/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies.
Autorzy:
Cieślik P; Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.
Siekierzycka A; Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.; Department of Medical Laboratory Diagnostics-Fahrenheit Biobank BBMRI.pl, Medical University of Gdańsk, 7 Dębinki Street, 80-211 Gdańsk, Poland.
Radulska A; Department of Medical Laboratory Diagnostics-Fahrenheit Biobank BBMRI.pl, Medical University of Gdańsk, 7 Dębinki Street, 80-211 Gdańsk, Poland.; Biobanking and Biomoleclular Resources Research Infrastructure Consortium Poland (BBMRI.pl), 7 Dębinki Street, 80-211 Gdańsk, Poland.
Płoska A; Department of Medical Laboratory Diagnostics-Fahrenheit Biobank BBMRI.pl, Medical University of Gdańsk, 7 Dębinki Street, 80-211 Gdańsk, Poland.; Biobanking and Biomoleclular Resources Research Infrastructure Consortium Poland (BBMRI.pl), 7 Dębinki Street, 80-211 Gdańsk, Poland.
Burnat G; Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.
Brański P; Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.
Kalinowski L; Department of Medical Laboratory Diagnostics-Fahrenheit Biobank BBMRI.pl, Medical University of Gdańsk, 7 Dębinki Street, 80-211 Gdańsk, Poland.; Biobanking and Biomoleclular Resources Research Infrastructure Consortium Poland (BBMRI.pl), 7 Dębinki Street, 80-211 Gdańsk, Poland.; BioTechMed Centre, Department of Mechanics of Materials and Structures, University of Technology, 11/12 Narutowicza, 80-233 Gdańsk, Poland.
Wierońska JM; Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Nov 13; Vol. 22 (22). Date of Electronic Publication: 2021 Nov 13.
Typ publikacji:
Journal Article
MeSH Terms:
Memory Disorders*/chemically induced
Memory Disorders*/metabolism
Cerebral Cortex/*metabolism
Dizocilpine Maleate/*adverse effects
Excitatory Amino Acid Antagonists/*adverse effects
Hippocampus/*metabolism
Nitric Oxide/*metabolism
Scopolamine/*adverse effects
Animals ; Dizocilpine Maleate/pharmacology ; Excitatory Amino Acid Antagonists/pharmacology ; Male ; Maze Learning/drug effects ; Mice ; Scopolamine/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An In Vivo Electroencephalographic Analysis of the Effect of Riluzole against Limbic and Absence Seizure and Comparison with Glutamate Antagonists.
Autorzy:
Citraro, Rita (AUTHOR)
Bosco, Francesca (AUTHOR)
Di Gennaro, Gianfranco (AUTHOR)
Tallarico, Martina (AUTHOR)
Guarnieri, Lorenza (AUTHOR)
Gallelli, Luca (AUTHOR)
Rania, Vincenzo (AUTHOR)
Siniscalchi, Antonio (AUTHOR)
De Sarro, Giovambattista (AUTHOR)
Leo, Antonio (AUTHOR)
Pokaż więcej
Źródło:
Pharmaceutics. Jul2023, Vol. 15 Issue 7, p2006. 22p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Memantine Modulates Oxidative Stress in the Rat Brain following Experimental Autoimmune Encephalomyelitis.
Autorzy:
Dąbrowska-Bouta B; Laboratory of Pathoneurochemistry, Department of Neurochemistry, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland.
Strużyńska L; Laboratory of Pathoneurochemistry, Department of Neurochemistry, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland.
Sidoryk-Węgrzynowicz M; Laboratory of Pathoneurochemistry, Department of Neurochemistry, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland.
Sulkowski G; Laboratory of Pathoneurochemistry, Department of Neurochemistry, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Oct 20; Vol. 22 (21). Date of Electronic Publication: 2021 Oct 20.
Typ publikacji:
Journal Article
MeSH Terms:
Brain/*drug effects
Brain/*metabolism
Encephalomyelitis, Autoimmune, Experimental/*drug therapy
Excitatory Amino Acid Antagonists/*pharmacology
Memantine/*pharmacology
Oxidative Stress/*drug effects
Animals ; Body Weight/drug effects ; Excitatory Amino Acid Antagonists/therapeutic use ; Female ; Memantine/therapeutic use ; Nervous System Diseases/drug therapy ; Rats, Inbred Lew ; Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors ; Superoxide Dismutase/genetics ; Superoxide Dismutase/metabolism ; Thiobarbituric Acid Reactive Substances/metabolism ; Rats
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Esketamine: a glimmer of hope in treatment-resistant depression.
Autorzy:
Kaur U; Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India.
Pathak BK; Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India.
Singh A; Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India.
Chakrabarti SS; Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India. .
Pokaż więcej
Źródło:
European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2021 Apr; Vol. 271 (3), pp. 417-429. Date of Electronic Publication: 2019 Nov 19.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Clinical Trials, Phase III as Topic*
Antidepressive Agents/*pharmacology
Depressive Disorder, Treatment-Resistant/*drug therapy
Excitatory Amino Acid Antagonists/*pharmacology
Ketamine/*pharmacology
Receptors, N-Methyl-D-Aspartate/*antagonists & inhibitors
Drug Therapy, Combination ; Excitatory Amino Acid Antagonists/adverse effects ; Excitatory Amino Acid Antagonists/pharmacokinetics ; Humans ; Ketamine/adverse effects ; Ketamine/pharmacokinetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Binding of a negative allosteric modulator and competitive antagonist can occur simultaneously at the ionotropic glutamate receptor GluA2.
Autorzy:
Krintel C; Research Cluster on Molecular Neuroprotection, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Dorosz J; Research Cluster on Molecular Neuroprotection, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Larsen AH; Structural Biophysics, X-ray and Neutron Science, The Niels Bohr Institute, University of Copenhagen, Denmark.
Thorsen TS; Research Cluster on Molecular Neuroprotection, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Venskutonytė R; Research Cluster on Molecular Neuroprotection, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.; Department of Experimental Medical Science, Lund University, Lund, 221 00, Sweden.
Mirza O; Research Cluster on Molecular Neuroprotection, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Gajhede M; Research Cluster on Molecular Neuroprotection, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Boesen T; Department of Molecular Biology and Genetics, Aarhus University, Denmark.
Kastrup JS; Research Cluster on Molecular Neuroprotection, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Pokaż więcej
Źródło:
The FEBS journal [FEBS J] 2021 Feb; Vol. 288 (3), pp. 995-1007. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Benzodiazepines/*metabolism
Excitatory Amino Acid Antagonists/*metabolism
Organophosphonates/*metabolism
Quinoxalines/*metabolism
Receptors, AMPA/*metabolism
Recombinant Proteins/*metabolism
Allosteric Regulation ; Animals ; Benzodiazepines/chemistry ; Benzodiazepines/pharmacology ; Crystallography, X-Ray ; Excitatory Amino Acid Antagonists/chemistry ; Excitatory Amino Acid Antagonists/pharmacology ; HEK293 Cells ; Humans ; Models, Molecular ; Molecular Structure ; Organophosphonates/chemistry ; Organophosphonates/pharmacology ; Protein Binding ; Protein Domains ; Quinoxalines/chemistry ; Quinoxalines/pharmacology ; Rats ; Receptors, AMPA/antagonists & inhibitors ; Receptors, AMPA/genetics ; Recombinant Proteins/chemistry ; Sf9 Cells ; Spodoptera
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy of ketamine for major depressive episodes at 2, 4, and 6-weeks post-treatment: A meta-analysis.
Autorzy:
Conley AA; Department of Psychology, Shippensburg University of Pennsylvania, Shippensburg, PA, 17257, USA. .
Norwood AEQ; Department of Psychology, Shippensburg University of Pennsylvania, Shippensburg, PA, 17257, USA.
Hatvany TC; Department of Psychology, Shippensburg University of Pennsylvania, Shippensburg, PA, 17257, USA.
Griffith JD; Department of Psychology, Shippensburg University of Pennsylvania, Shippensburg, PA, 17257, USA.
Barber KE; Department of Psychology, Shippensburg University of Pennsylvania, Shippensburg, PA, 17257, USA.
Pokaż więcej
Źródło:
Psychopharmacology [Psychopharmacology (Berl)] 2021 Jul; Vol. 238 (7), pp. 1737-1752. Date of Electronic Publication: 2021 Mar 31.
Typ publikacji:
Journal Article; Meta-Analysis; Review
MeSH Terms:
Clinical Trials as Topic/*methods
Depressive Disorder, Major/*drug therapy
Depressive Disorder, Major/*psychology
Excitatory Amino Acid Antagonists/*therapeutic use
Ketamine/*therapeutic use
Affect/drug effects ; Affect/physiology ; Depressive Disorder, Major/diagnosis ; Excitatory Amino Acid Antagonists/pharmacology ; Humans ; Ketamine/pharmacology ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Hyperammonaemia disrupts daily rhythms reversibly by elevating glutamate in the central circadian pacemaker.
Autorzy:
Granados‐Fuentes, Daniel (AUTHOR)
Cho, Kevin (AUTHOR)
Patti, Gary J. (AUTHOR)
Costa, Rodolfo (AUTHOR)
Herzog, Erik D. (AUTHOR)
Montagnese, Sara (AUTHOR)
Pokaż więcej
Źródło:
Liver International. Mar2023, Vol. 43 Issue 3, p673-683. 11p. 1 Color Photograph, 4 Graphs.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches.
Autorzy:
Cruz-Vicente P; CICS-UBI, Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.; UCIBIO-Applied Molecular Biosciences Unit, Department of Chemistry, Faculty of Sciences and Technology, NOVA University Lisbon, 2829-516 Caparica, Portugal.
Passarinha LA; CICS-UBI, Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.; UCIBIO-Applied Molecular Biosciences Unit, Department of Chemistry, Faculty of Sciences and Technology, NOVA University Lisbon, 2829-516 Caparica, Portugal.; Laboratory of Pharmaco-Toxicology-UBIMedical, University of Beira Interior, 6200-001 Covilhã, Portugal.
Silvestre S; CICS-UBI, Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.; Laboratory of Pharmaco-Toxicology-UBIMedical, University of Beira Interior, 6200-001 Covilhã, Portugal.; CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
Gallardo E; CICS-UBI, Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.; Laboratory of Pharmaco-Toxicology-UBIMedical, University of Beira Interior, 6200-001 Covilhã, Portugal.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2021 Apr 11; Vol. 26 (8). Date of Electronic Publication: 2021 Apr 11.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Alzheimer Disease/*drug therapy
Antiparkinson Agents/*therapeutic use
Cholinesterase Inhibitors/*therapeutic use
Dopamine Agents/*therapeutic use
Excitatory Amino Acid Antagonists/*therapeutic use
Neuroprotective Agents/*therapeutic use
Parkinson Disease/*drug therapy
Acetylcholinesterase/genetics ; Acetylcholinesterase/metabolism ; Alzheimer Disease/genetics ; Alzheimer Disease/metabolism ; Alzheimer Disease/pathology ; Amyloid Precursor Protein Secretases/antagonists & inhibitors ; Amyloid Precursor Protein Secretases/genetics ; Amyloid Precursor Protein Secretases/metabolism ; Antiparkinson Agents/chemical synthesis ; Aspartic Acid Endopeptidases/antagonists & inhibitors ; Aspartic Acid Endopeptidases/genetics ; Aspartic Acid Endopeptidases/metabolism ; Catechol O-Methyltransferase/genetics ; Catechol O-Methyltransferase/metabolism ; Cholinesterase Inhibitors/chemical synthesis ; Clinical Trials as Topic ; Computer Simulation ; Dopamine Agents/chemical synthesis ; Drug Design ; Excitatory Amino Acid Antagonists/chemical synthesis ; GPI-Linked Proteins/antagonists & inhibitors ; GPI-Linked Proteins/genetics ; GPI-Linked Proteins/metabolism ; Gene Expression Regulation ; Humans ; Neuroprotective Agents/chemical synthesis ; Parkinson Disease/genetics ; Parkinson Disease/metabolism ; Parkinson Disease/pathology ; Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors ; Receptors, N-Methyl-D-Aspartate/genetics ; Receptors, N-Methyl-D-Aspartate/metabolism ; Sirtuins/antagonists & inhibitors ; Sirtuins/genetics ; Sirtuins/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients.
Autorzy:
Chen X; The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, 510370, China.; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Mingxin Rd.36, Guangzhou, 510370, Guangdong, China.
Wang M; The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, 510370, China.; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Mingxin Rd.36, Guangzhou, 510370, Guangdong, China.
Hu Y; The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, 510370, China.; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Mingxin Rd.36, Guangzhou, 510370, Guangdong, China.
Zhan Y; The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, 510370, China.; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Mingxin Rd.36, Guangzhou, 510370, Guangdong, China.
Zhou Y; The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, 510370, China.; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Mingxin Rd.36, Guangzhou, 510370, Guangdong, China.
Zheng W; The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, 510370, China.; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Mingxin Rd.36, Guangzhou, 510370, Guangdong, China.
Liu W; The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, 510370, China.; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Mingxin Rd.36, Guangzhou, 510370, Guangdong, China.
Wang C; The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, 510370, China.; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Mingxin Rd.36, Guangzhou, 510370, Guangdong, China.
Zhong X; The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, 510370, China.; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Mingxin Rd.36, Guangzhou, 510370, Guangdong, China.
Li H; The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, 510370, China.; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Mingxin Rd.36, Guangzhou, 510370, Guangdong, China.
Lan X; The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, 510370, China.; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Mingxin Rd.36, Guangzhou, 510370, Guangdong, China.
Ning Y; The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, 510370, China. .; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Mingxin Rd.36, Guangzhou, 510370, Guangdong, China. .
Zhang B; The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, 510370, China.; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Mingxin Rd.36, Guangzhou, 510370, Guangdong, China.
Pokaż więcej
Źródło:
European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2021 Apr; Vol. 271 (3), pp. 431-438. Date of Electronic Publication: 2021 Jan 01.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Suicidal Ideation*
Antidepressive Agents/*pharmacology
Cognitive Dysfunction/*drug therapy
Depressive Disorder, Major/*drug therapy
Excitatory Amino Acid Antagonists/*pharmacology
Ketamine/*pharmacology
Memory, Short-Term/*drug effects
Adult ; Antidepressive Agents/administration & dosage ; Cognitive Dysfunction/etiology ; Depressive Disorder, Major/complications ; Excitatory Amino Acid Antagonists/administration & dosage ; Female ; Humans ; Infusions, Intravenous ; Ketamine/administration & dosage ; Male ; Middle Aged ; Outcome Assessment, Health Care ; Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
NMDA glutamate receptor antagonist MK‐801 induces proteome changes in adult human brain slices which are partially counteracted by haloperidol and clozapine.
Autorzy:
de Almeida, Valéria (AUTHOR)
Mendes, Niele Dias (AUTHOR)
Zuccoli, Giuliana S. (AUTHOR)
Reis‐de‐Oliveira, Guilherme (AUTHOR)
Almeida, Glaucia M. (AUTHOR)
Podolsky‐Gondim, Guilherme Gozzoli (AUTHOR)
Neder, Luciano (AUTHOR)
Martins‐de‐Souza, Daniel (AUTHOR)
Sebollela, Adriano (AUTHOR)
Pokaż więcej
Źródło:
Journal of Neurochemistry. Mar2024, Vol. 168 Issue 3, p238-250. 13p.
Czasopismo naukowe
Szczegóły
Tytuł:
The Effect of Ketamine on Endoplasmic Reticulum Stress in Rats with Neuropathic Pain.
Autorzy:
Seo EH; Korea mRNA Vaccine Initiative, School of Medicine, Gachon University, Incheon 21565, Republic of Korea.
Piao L; Department of Infection and Immunology, School of Medicine, Konkuk University, Seoul 05030, Republic of Korea.
Cho EH; Department of Infection and Immunology, School of Medicine, Konkuk University, Seoul 05030, Republic of Korea.
Hong SW; Department of Anesthesiology and Pain Medicine, Konkuk University Medical Center, School of Medicine, Konkuk University, Neudong-ro (Hwayang-dong), Seoul 05030, Republic of Korea.
Kim SH; Department of Infection and Immunology, School of Medicine, Konkuk University, Seoul 05030, Republic of Korea.; Department of Anesthesiology and Pain Medicine, Konkuk University Medical Center, School of Medicine, Konkuk University, Neudong-ro (Hwayang-dong), Seoul 05030, Republic of Korea.; Department of Medicine, Institute of Biomedical Science and Technology, School of Medicine, Konkuk University, Seoul 05030, Republic of Korea.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Mar 10; Vol. 24 (6). Date of Electronic Publication: 2023 Mar 10.
Typ publikacji:
Journal Article
MeSH Terms:
Ketamine*/pharmacology
Ketamine*/therapeutic use
Neuralgia*/drug therapy
Neuralgia*/metabolism
Rats ; Animals ; Rats, Sprague-Dawley ; Excitatory Amino Acid Antagonists/pharmacology ; Pain Measurement ; Receptors, N-Methyl-D-Aspartate/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The positive allosteric modulator of NMDA receptors, GNE-9278, blocks the ethanol-induced decrease of excitability in developing retrosplenial cortex neurons from mice.
Autorzy:
Bird CW; Department of Neurosciences, School of Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
Valenzuela CF; Department of Neurosciences, School of Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
Pokaż więcej
Źródło:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2023 Mar; Vol. 43 (1), pp. 77-84. Date of Electronic Publication: 2022 Dec 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Ethanol*
Central Nervous System Depressants*/pharmacology
Animals ; Mice ; Receptors, N-Methyl-D-Aspartate/metabolism ; Gyrus Cinguli/metabolism ; N-Methylaspartate/pharmacology ; Excitatory Amino Acid Antagonists/pharmacology ; Neurons/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network.
Autorzy:
Qin Y; Université de Strasbourg, Strasbourg, France.; INSERM U1114, Neuropsychologie cognitive et physiopathologie de la schizophrénie, Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Faculté de médecine, Strasbourg, France.; Centre de Recherche en Biomédecine de Strasbourg (CRBS), Strasbourg, France.; Netherlands Institute for Neuroscience, The Netherlands.
Mahdavi A; Université de Strasbourg, Strasbourg, France.; INSERM U1114, Neuropsychologie cognitive et physiopathologie de la schizophrénie, Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Faculté de médecine, Strasbourg, France.; Centre de Recherche en Biomédecine de Strasbourg (CRBS), Strasbourg, France.; The University of Freiburg, Bernstein Center Freiburg, Freiburg, Germany.
Bertschy M; Université de Strasbourg, Strasbourg, France.; INSERM U1114, Neuropsychologie cognitive et physiopathologie de la schizophrénie, Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Faculté de médecine, Strasbourg, France.; Centre de Recherche en Biomédecine de Strasbourg (CRBS), Strasbourg, France.
Anderson PM; Dept. Cognitive Neurobiology, Center for Brain Research, Medical University Vienna, Austria.
Kulikova S; National Research University Higher School of Economics, Perm, Russia.
Pinault D; Université de Strasbourg, Strasbourg, France.; INSERM U1114, Neuropsychologie cognitive et physiopathologie de la schizophrénie, Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Faculté de médecine, Strasbourg, France.; Centre de Recherche en Biomédecine de Strasbourg (CRBS), Strasbourg, France.
Pokaż więcej
Źródło:
The European journal of neuroscience [Eur J Neurosci] 2023 Feb; Vol. 57 (3), pp. 440-455. Date of Electronic Publication: 2022 Nov 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Ketamine*/pharmacology
Rats ; Animals ; Excitatory Amino Acid Antagonists/pharmacology ; Receptors, N-Methyl-D-Aspartate ; Brain ; Thalamus
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ketamine: Linking NMDA receptor hypofunction, gamma oscillations and psychosis (commentary on Qin et al., 2022).
Autorzy:
Reilly TJ; Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
Pokaż więcej
Źródło:
The European journal of neuroscience [Eur J Neurosci] 2023 Feb; Vol. 57 (3), pp. 456-457. Date of Electronic Publication: 2022 Dec 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Ketamine*/pharmacology
Psychotic Disorders*/drug therapy
Humans ; Receptors, N-Methyl-D-Aspartate/physiology ; Excitatory Amino Acid Antagonists
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 2246

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies